title: Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats.
abstract: In this study, the effect of dahi containing probiotic Lactobacillus acidophilus NCDC14 and Lactobacillus casei NCDC19 (73 x 10(8) cfu/g) on progression of streptozotocin (STZ)-induced diabetes in rats (15 g/day/rat) for 28 days was investigated. Feeding of probiotic dahi significantly suppressed the incremental peaks and area under the curve and delayed reduction of insulin secretion during oral glucose tolerance test more than skim milk or control dahi. The feeding of milk products reduced the total cholesterol, triglycerides, LDL and VLDL-cholesterol and increased HDL-cholesterol levels (P<0.05). Moreover, probiotic dahi significantly suppressed STZ-induced oxidative damage in pancreatic tissues by inhibiting the lipid peroxidation and formation of nitric oxide, and preserving antioxidant pool such as glutathione content and activities of superoxide dismutase, catalase and glutathione peroxidase. The results suggest that the supplementation of probiotic Lb. acidophilus and Lb. casei with dahi cultures increased the efficacy of dahi to suppress STZ-induced diabetes in rats by inhibiting depletion of insulin as well as preserving diabetic dyslipidemia, and inhibiting lipid peroxidation and nitrite formation. This may empower antioxidant system of beta-cells and may slow down the reduction of insulin and elevation of blood glucose levels.
authors.affiliation: Animal Biochemistry Division, National Dairy Research Institute, Karnal 132001 Haryana, India. yadavh@mail.nih.gov
authors.forename: Hariom
authors.initials: H
authors.lastname: Yadav
authors.forename: Shalini
authors.initials: S
authors.lastname: Jain
authors.forename: Pushpalata Ravindra
authors.initials: PR
authors.lastname: Sinha
mesh_terms: D000284:Administration, Oral; D000818:Animals; D019540:Area Under Curve; D001786:Blood Glucose / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000628:therapy*; D005951:Glucose Tolerance Test; D007328:Insulin / Q000097:blood; D007779:Lactobacillus acidophilus; D007780:Lacticaseibacillus casei; D050356:Lipid Metabolism; D008297:Male; D018384:Oxidative Stress; D019936:Probiotics / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D013311:Streptozocin; D013997:Time Factors; D015014:Yogurt / Q000382:microbiology*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D013311:Streptozocin